Question: In which of the following country the Sinopharm COVID-19 vaccine
has been developed?
a) India
b) France
c) China
d) Britain
Answer: (c)
Related Facts:-
- On 7 May 2021; WHO listed the Sinopharm COVID-19 vaccine for emergency use and has given the green light for this vaccine to be rolled out globally.
- The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, subsidiary of China National Biotec Group (CNBG).
- According to Dr Mariângela Simão, WHO Assistant-Director General for Access to Health Products, the addition of this vaccine has the potential to rapidly accelerate COVID-19 vaccine access for countries seeking to protect health workers and populations at risk.
- The Sinopharm product is an inactivated vaccine called SARS-CoV-2 Vaccine (Vero Cell).
- Its easy storage requirements make it highly suitable for low-resource settings.
- It is the also first vaccine that will carry a vaccine vial monitor, a small sticker on the vaccine vials that change color as the vaccine is exposed to heat, letting health workers know whether the vaccine can be safely used.